Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class ASSE: 688505

Announcement on Voluntary Disclosure of Obtaining Notice on Acceptance of Drug Clinical Trial Application for FZ-P001 Sodium for Injection for Intraoperative Visualization of Malignant Lesions in Cancer

· Issued by Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Obtaining Notice on Acceptance of Drug Clinical Trial Application for FZ-P001 Sodium for Injection for Intraoperative Visualization of Malignant Lesions in Cancer

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis